دورية أكاديمية
[Antibody-mediated rejection of renal allograft and the update Banff classification 2013].
| العنوان: | [Antibody-mediated rejection of renal allograft and the update Banff classification 2013]. |
|---|---|
| عنوان ترانسليتريتد: | Humorální rejekce a aktualizace Banffské klasifikace 2013. |
| المؤلفون: | Honsová E |
| المصدر: | Ceskoslovenska patologie [Cesk Patol] 2015; Vol. 51 (3), pp. 116-9. |
| نوع المنشور: | Journal Article |
| اللغة: | Czech |
| بيانات الدورية: | Publisher: Ceska Lekarska Spolecnost Country of Publication: Czech Republic NLM ID: 0050734 Publication Model: Print Cited Medium: Print ISSN: 1210-7875 (Print) Linking ISSN: 12107875 NLM ISO Abbreviation: Cesk Patol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Praha : Ceska Lekarska Spolecnost Original Publication: Praha : Státní zdravotnické nakladatelství, 1965- |
| مواضيع طبية MeSH: | Complement C4b/*immunology , Graft Rejection/*diagnosis , Kidney/*immunology , Kidney Transplantation/*adverse effects, Graft Rejection/immunology ; HLA Antigens ; Humans ; Kidney/pathology ; Tissue Donors |
| مستخلص: | The view on the role of donor-specific antibodies in organ transplantation has been changed during the last several decades. Today, it is considered that the majority of cases of the late renal allograft dysfunction and loss are caused by the presence of donor-specific antibodies to HLA antigens. The real breakthrough in the diagnosis of antibody-mediated rejection was represented by the discovery of C4d, which enabled the determination of the diagnostic criteria of acute and later chronic antibody-mediated rejection. Although detection of C4d has been the cornerstone in the diagnosis of antibody-mediated rejection for over 10 years, it has become clear that some cases with similar morphological and clinical features do not have detectable C4d. Outcomes of key studies concerning presence of donor specific antibodies and morphological features in the graft biopsy samples resulted in the modification of Banff classification of 2013, which includes integrating C4d negative antibody-mediated rejection and also that acute vascular rejection (v1, v2) can be a part of the antibody-mediated rejection. |
| فهرسة مساهمة: | Keywords: kidney allograft - antibody-mediated rejection - T-cell mediated rejection. |
| المشرفين على المادة: | 0 (HLA Antigens) 80295-50-7 (Complement C4b) |
| تواريخ الأحداث: | Date Created: 20151001 Date Completed: 20180423 Latest Revision: 20181202 |
| رمز التحديث: | 20240829 |
| PMID: | 26421951 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1210-7875 |
|---|